Role of autophagy in metabolic syndrome-associated heart disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 2, 2015, Pages 225-231

  Ren, Sidney Y ^a   Xu, Xihui ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Autophagy; Heart; High fat diet; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PROTEIN; STREPTOZOCIN;

AUTOLYSOSOME; AUTOPHAGY; CLINICAL OBSERVATION; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HEART DISEASE; HEART FUNCTION; HEART INJURY; HEART OUTPUT; HUMAN; INSULIN RESISTANCE; LIPID DIET; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PROTEIN DEGRADATION; PROTEIN QUALITY; QUALITY CONTROL; REVIEW; RISK FACTOR; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; METABOLISM; PATHOLOGY;

ANIMALS; AUTOPHAGY; HEART DISEASES; HUMANS; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; PROTEINS;

EID: 84919786439     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.029     Document Type: Review

References (56)

1. Despres J.P. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993, 9:452-459.
2. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15:539-553.
3. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16:442-443.
4. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404.
5. Xu X., Ren J. Cardiac stem cell regeneration in metabolic syndrome. Curr. Pharm. Des. 2013, 19:4888-4892.
6. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
7. Ford E.S., Giles W.H., Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27:2444-2449.
8. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart Disease and Stroke Statistics-2013 Update: a report from the American Heart Association. Circulation 2013, 127:e6-e245. 10.1161/CIR.0b013e31828124ad.
9. de Ferranti S.D., Gauvreau K., Ludwig D.S., Neufeld E.J., Newburger J.W., Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004, 110:2494-2497. 10.1161/01.CIR.0000145117.40114.C7.
10. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., Allen K., Lopes M., Savoye M., Morrison J., Sherwin R.S., Caprio S. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 2004, 350:2362-2374. 10.1056/NEJMoa031049.
11. Li Z.L., Woollard J.R., Ebrahimi B., Crane J.A., Jordan K.L., Lerman A., Wang S.M., Lerman L.O. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1132-1141. 10.1161/ATVBAHA.111.244061.
12. Xu X., Hua Y., Nair S., Zhang Y., Ren J. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J. Mol. Cell Biol. 2013, 5:61-63. 10.1093/jmcb/mjs055.
13. Xu X., Ren J. Unmasking the janus faces of autophagy in obesity-associated insulin resistance and cardiac dysfunction. Clin. Exp. Pharmacol. Physiol. 2012, 39:200-208. 10.1111/j.1440-1681.2011.05638.x.
14. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326. 10.1016/j.cell.2010.01.028.
15. Qu X., Zou Z., Sun Q., Luby-Phelps K., Cheng P., Hogan R.N., Gilpin C., Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007, 128:931-946. 10.1016/j.cell.2006.12.044.
16. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., Omiya S., Mizote I., Matsumura Y., Asahi M., Nishida K., Hori M., Mizushima N., Otsu K. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624. 10.1038/nm1574.
17. Xu X., Roe N.D., Weiser-Evans M.C., Ren J. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN. Hypertension 2014, 63:729-739. 10.1161/HYPERTENSIONAHA.113.02526.
18. Matsui Y., Kyoi S., Takagi H., Hsu C.P., Hariharan N., Ago T., Vatner S.F., Sadoshima J. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008, 4:409-415.
19. Xu X., Hua Y., Nair S., Bucala R., Ren J. Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy. Hypertension 2014, 63:490-499. 10.1161/HYPERTENSIONAHA.113.02219.
20. Xu X., Bucala R., Ren J. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy. J. Am. Heart Assoc. 2013, 2:e000439. 10.1161/JAHA.113.000439.
21. Cui M., Yu H., Wang J., Gao J., Li J. Chronic caloric restriction and exercise improve metabolic conditions of dietary-induced obese mice in autophagy correlated manner without involving AMPK. J. Diabetes Res. 2013, 2013:852754. 10.1155/2013/852754.
22. Lancel S., Montaigne D., Marechal X., Marciniak C., Hassoun S.M., Decoster B., Ballot C., Blazejewski C., Corseaux D., Lescure B., Motterlini R., Neviere R. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One 2012, 7:e41836. 10.1371/journal.pone.0041836.
23. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
24. Resnick H.E., Jones K., Ruotolo G., Jain A.K., Henderson J., Lu W., Howard B.V. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003, 26:861-867.
25. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
26. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004, 27:2676-2681.
27. Park H.E., Choi S.Y., Kim M. Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2-dimensional echocardiography. BMC Cardiovasc. Disord. 2014, 14:3. 10.1186/1471-2261-14-3.
28. Turhan H., Yasar A.S., Yagmur J., Kurtoglu E., Yetkin E. The impact of metabolic syndrome on left ventricular function: evaluated by using the index of myocardial performance. Int. J. Cardiol. 2009, 132:382-386. 10.1016/j.ijcard.2007.12.007.
29. Masugata H., Senda S., Goda F., Yoshihara Y., Yoshikawa K., Fujita N., Daikuhara H., Nakamura H., Taoka T., Kohno M. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens. Res. 2006, 29:897-903. 10.1291/hypres.29.897.
30. Gong H.P., Tan H.W., Fang N.N., Song T., Li S.H., Zhong M., Zhang W., Zhang Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res. Clin. Pract. 2009, 83:300-307. 10.1016/j.diabres.2008.10.018.
31. Hwang Y.C., Jee J.H., Kang M., Rhee E.J., Sung J., Lee M.K. Metabolic syndrome and insulin resistance are associated with abnormal left ventricular diastolic function and structure independent of blood pressure and fasting plasma glucose level. Int. J. Cardiol. 2012, 159:107-111. 10.1016/j.ijcard.2011.02.039.
32. Ceylan-Isik A.F., Kandadi M.R., Xu X., Hua Y., Chicco A.J., Ren J., Nair S. Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J. Mol. Cell. Cardiol. 2013, 63:4-13. 10.1016/j.yjmcc.2013.07.002.
33. Hua Y., Zhang Y., Dolence J., Shi G.P., Ren J., Nair S. Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction. Diabetes 2013, 62:498-509. 10.2337/db12-0350.
34. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
35. Xu X., Pacheco B.D., Leng L., Bucala R., Ren J. Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy. Cardiovasc. Res. 2013, 99:412-421. 10.1093/cvr/cvt116.
36. Sun M., Ouzounian M., de Couto G., Chen M., Yan R., Fukuoka M., Li G., Moon M., Liu Y., Gramolini A., Wells G.J., Liu P.P. Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways. J Am Heart Assoc 2013, 2:e000191. 10.1161/JAHA.113.000191.
37. Goldman S.J., Zhang Y., Jin S. Autophagic degradation of mitochondria in white adipose tissue differentiation. Antioxid. Redox Signal. 2011, 14:1971-1978. 10.1089/ars.2010.3777.
38. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93. 10.1146/annurev-genet-102808-114910.
39. Zhang Y., Xu X., Ren J. MTOR overactivation and interrupted autophagy flux in obese hearts: a dicey assembly?. Autophagy 2013, 9:939-941. 10.4161/auto.24398.
40. Jung C.H., Ro S.H., Cao J., Otto N.M., Kim D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295. 10.1016/j.febslet.2010.01.017.
41. Hua Y., Zhang Y., Ceylan-Isik A.F., Wold L.E., Nunn J.M., Ren J. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res. Cardiol. 2011, 106:1173-1191. 10.1007/s00395-011-0222-8.
42. Xu X., Hueckstaedt L.K., Ren J. Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy. J. Hepatol. 2013, 59:308-317. 10.1016/j.jhep.2013.03.037.
43. Lee C.H., Inoki K., Guan K.L. mTOR pathway as a target in tissue hypertrophy. Annu. Rev. Pharmacol. Toxicol. 2007, 47:443-467. 10.1146/annurev.pharmtox.47.120505.105359.
44. Cai S.L., Tee A.R., Short J.D., Bergeron J.M., Kim J., Shen J., Guo R., Johnson C.L., Kiguchi K., Walker C.L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 2006, 173:279-289. 10.1083/jcb.200507119.
45. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 2010, 107:1470-1482. 10.1161/CIRCRESAHA.110.227371.
46. Guo R., Ren J. Deficiency in AMPK attenuates ethanol-induced cardiac contractile dysfunction through inhibition of autophagosome formation. Cardiovasc. Res. 2012, 94:480-491. 10.1093/cvr/cvs127.
47. Brady N.R., Hamacher-Brady A., Yuan H., Gottlieb R.A. The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic reticulum calcium stores. FEBS J. 2007, 274:3184-3197. 10.1111/j.1742-4658.2007.05849.x.
48. Cao D.J., Wang Z.V., Battiprolu P.K., Jiang N., Morales C.R., Kong Y., Rothermel B.A., Gillette T.G., Hill J.A. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4123-4128. 10.1073/pnas.1015081108.
49. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., Le V., Levine B., Rothermel B.A., Hill J.A. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 2007, 117:1782-1793. 10.1172/JCI27523.
50. Guo R., Zhang Y., Turdi S., Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim. Biophys. Acta 2013, 1832:1136-1148. 10.1016/j.bbadis.2013.03.013.
51. He C., Bassik M.C., Moresi V., Sun K., Wei Y., Zou Z., An Z., Loh J., Fisher J., Sun Q., Korsmeyer S., Packer M., May H.I., Hill J.A., Virgin H.W., Gilpin C., Xiao G., Bassel-Duby R., Scherer P.E., Levine B. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481:511-515. 10.1038/nature10758.
52. Sciarretta S., Zhai P., Shao D., Maejima Y., Robbins J., Volpe M., Condorelli G., Sadoshima J. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 2012, 125:1134-1146. 10.1161/CIRCULATIONAHA.111.078212.
53. Xie Z., Lau K., Eby B., Lozano P., He C., Pennington B., Li H., Rathi S., Dong Y., Tian R., Kem D., Zou M.H. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 2011, 60:1770-1778. 10.2337/db10-0351.
54. Xu X., Kobayashi S., Chen K., Timm D., Volden P., Huang Y., Gulick J., Yue Z., Robbins J., Epstein P.N., Liang Q. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J. Biol. Chem. 2013, 288:18077-18092. 10.1074/jbc.M113.474650.
55. Mellor K.M., Bell J.R., Young M.J., Ritchie R.H., Delbridge L.M. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J. Mol. Cell. Cardiol. 2011, 50:1035-1043. 10.1016/j.yjmcc.2011.03.002.
56. Reznick R.M., Shulman G.I. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 2006, 574:33-39. 10.1113/jphysiol.2006.109512.